StockGlow

Saniona AB (publ) (SANION.ST)

Develops experimental medicines targeting brain disorders by modulating ion channels

14.15+0.05%Healthcare
Compare SANION.ST with
StockGlow Score
44
Neutral
BearishBullish
1 year ago+54.8%

The outlook

Saniona trades near the lower end of its 52-week range, with mixed signals from its moving averages. Analyst price targets sit roughly 41% above the current level, though coverage appears limited. The stock carries a neutral overall lean with a trailing P/E of 8.5.

What’s behind the score

Price trendMixed vs its moving averages
52-week range30% of the way from its 52-week low to high
Price targetAvg target +41% vs current price
Market cap
$1.95B
52-wk high
28.30
52-wk low
8.03
50-day avg
13.24
200-day avg
17.14
Trailing P/E
8.5

Similar stocks

HNSA.STHansa Biopharma AB (publ)$36.84-0.59%GOMX.STGomSpace Group AB (publ)$12.55+3.98%BINV.STBioInvent International AB (publ)$23.10-1.07%EXPRS2.STExpreS2ion Biotech Holding AB (publ)$1.43+1.79%CANTA.STCantargia AB (publ)$1.89+1.07%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy